ReadyGo Diagnostics Unveils Groundbreaking Single-Tube Mpox Virus Detection Assay

ReadyGo Diagnostics Ltd. (ReadyGo™), an innovator in diagnostic technology solutions, is excited to announce a co-development agreement with SureScreen Diagnostics Ltd., a global leader in rapid diagnostics to research, develop, and commercialise a groundbreaking product aimed at the drink spike testing market.

ReadyGo Diagnostics Ltd. is thrilled to unveil a strategic partnership with Porex, a global leader in custom-engineered porous polymer solutions.

ReadyGo™ and Gemina are pleased to announce the expansion of their partnership with an additional agreement focused on developing a molecular diagnostic test on the Geo™ platform specifically designed for the detection of dengue from saliva samples.

ReadyGo™ and Gemina are delighted to announce the successful demonstration of the viability of using saliva as a sample for detecting Mycobacterium tuberculosis (MTB) via a molecular diagnostic test.

Headed by a team of diagnostics industry veterans, ReadyGo Diagnostics emerged last week from two years in stealth mode with plans to parlay a novel sample prep method, two isothermal molecular diagnostics systems, and assay development expertise into commercialisation partnerships with other companies.

ReadyGo Diagnostics and Gemina Laboratories Ltd agree development of molecular diagnostic test for Mycobacterium tuberculosis (MTB) detection on ReadyGo’s diagnostic platform, Geo™.

Reporting back on new R&D and development capital.

How Sampler is reducing plastic used in diagnostics.

We’re delighted to be in Bath, with labs in operation.